Silence Therapeutics

SLN NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Revenue $2,099 $2,798 $9,104 $11,374
Gross Profit 753 1,191 6,273 6,840
EBITDA -14,908 -10,528 -10,999 -11,679
EBIT -15,029 -10,653 -11,117 -12,149
Net Income -14,412 -8,250 -10,401 -10,204
Net Change In Cash 2,099 2,798 9,104 11,374
Free Cash Flow -11,867 -4,892 -14,953 -7,689
Cash 54,031 58,812 29,720 46,731
Basic Shares 38,920 37,305 36,162 35,980

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $25,375 $17,501 $12,415 $5,479
Gross Profit 15,057 6,621 4,959 1,717
EBITDA -47,660 -47,885 -45,377 -35,222
EBIT -48,158 -48,593 -45,814 -35,847
Net Income -43,267 -40,489 -39,410 -32,547
Net Change In Cash 25,375 17,501 12,415 5,479
Free Cash Flow -39,395 -45,896 5,472 -11,290
Cash 54,031 54,816 73,537 27,449
Basic Shares 37,092 32,194 29,650 27,258

Earnings Calls

Quarter EPS
2024-03-31 $0
2023-12-31 -$0.45
2023-09-30 -$0.07
2023-06-30 -$0.12